The Current Ratio of Keros Therapeutics, Inc. (KROS) is
15.45.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
15.45
|
| 2024-12-31 |
21.45
|
| 2023-12-31 |
14.25
|
| 2022-12-31 |
17.32
|
| 2021-12-31 |
21.31
|
| 2020-12-31 |
37.18
|
| 2019-12-31 |
1.98
|
| 2018-12-31 |
2.22
|
| Ticker |
Name |
Value |
|
QURE
|
uniQure N.V.
|
10.43
|
|
VBIV
|
VBI Vaccines Inc
|
0.48
|
|
ALEC
|
Alector, Inc.
|
3.83
|
|
ARQT
|
Arcutis Biotherapeutics, Inc.
|
3.17
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
KRON
|
Kronos Bio LLC
|
7.54
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
CMPS
|
Compass Pathways PLC
|
0.77
|
|
CYTK
|
Cytokinetics, Incorporated
|
4.53
|
|
NKTX
|
Nkarta, Inc.
|
12.69
|
|
REPL
|
Replimune Group, Inc.
|
4.79
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
OCGN
|
Ocugen, Inc.
|
1.06
|
|
STTK
|
Shattuck Labs Inc
|
11.70
|
|
ABBV
|
AbbVie Inc.
|
0.67
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7.81
|
|
IMVT
|
Immunovant, Inc.
|
9.09
|
|
KNTE
|
Kinnate Biopharma Inc
|
13.19
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|
|
PCVX
|
Vaxcyte, Inc.
|
7.91
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
CYDY
|
Cytodyn Inc
|
0.26
|
|
FPRX
|
Five Prime Therapeutics Inc
|
13.18
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
KRYS
|
Krystal Biotech, Inc.
|
9.95
|
|
PAND
|
Pandion Therapeutics Inc
|
2.84
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
9.39
|
|
ZYME
|
Zymeworks Inc.
|
5.88
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
STOK
|
Stoke Therapeutics, Inc.
|
5.28
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
4.16
|